Uses of Irradiated Human Amniotic Membrane in the Treatment of Dystrophic Epidermolysis Bullosa Patients
NCT ID: NCT03942250
Last Updated: 2023-09-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
8 participants
INTERVENTIONAL
2017-01-31
2019-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Using of Irradiated Amnion Dressing for the Treatment of Skin Ulcer
NCT03440528
A Comparative Study of the Healing of Chronic Ulcers of Recessive Epidermolysis Bullosa : Dressing vs Amniotic Membrane
NCT02286427
Amniotic Membrane for Donor Site Healing
NCT02947737
Human Amniotic Versus Synthetic Membrane as a Transient Skin Cover for Pediatric Burns
NCT02904941
Clinic Trial in Phase 1 Using Amniotic Membrane for the Skin Replacement in Big Wounds
NCT01948934
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Treated
Patients who received REGE pro dressing on EB wounds lesion weekly for 10 weeks
REGE pro dressing
REGE pro is a dressing of dried human amniotic membrane sterilized by gamma radiation
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
REGE pro dressing
REGE pro is a dressing of dried human amniotic membrane sterilized by gamma radiation
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
2. Exclude patients have:
1. Autoimmune diseases
2. Diabetes
12 Years
45 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Waleed Nemr,Egyptian Atomic Energy Authority
UNKNOWN
Egyptian Atomic Energy Authority
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Nashwa Radwan
Head of amniotic tissue laboratory, Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Nashwa K Radwan, PhD
Role: STUDY_DIRECTOR
NATIONAL CENTER FOR RADIATION RESEARCH AND TECHNOLOGY
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Amniotic tissue lab
Cairo, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Nemr W, Bashandy AS, Araby E, Khamiss O. Biological Activity Alterations of Human Amniotic Membrane Pre and Post Irradiation Tissue Banking. Pak J Biol Sci. 2016;19(7):289-298. doi: 10.3923/pjbs.2016.289.298.
Lo V, Lara-Corrales I, Stuparich A, Pope E. Amniotic membrane grafting in patients with epidermolysis bullosa with chronic wounds. J Am Acad Dermatol. 2010 Jun;62(6):1038-44. doi: 10.1016/j.jaad.2009.02.048.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2222018NCRRT
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.